{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:07:58Z","timestamp":1794366478904,"version":"4.9.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T00:00:00Z","timestamp":1764028800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K21257"],"award-info":[{"award-number":["19K21257"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23K14517"],"award-info":[{"award-number":["23K14517"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16K19123"],"award-info":[{"award-number":["16K19123"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"MEXT | Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07107"],"award-info":[{"award-number":["18K07107"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["23ae0121040h0003"],"award-info":[{"award-number":["23ae0121040h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["223fa627003h0001"],"award-info":[{"award-number":["223fa627003h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["J22JK00035"],"award-info":[{"award-number":["J22JK00035"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Botulinum toxins (BoNTs) produced by\n                    <jats:italic>Clostridium botulinum<\/jats:italic>\n                    are the most potent known bacterial toxins. The BoNT complex from serotype B-Okra (LPTC\/B\n                    <jats:sup>Okra<\/jats:sup>\n                    ) exerts at least 80-fold higher oral toxicity in mice compared with that from serotype A1 (L-PTC\/A\n                    <jats:sup>62A<\/jats:sup>\n                    ). Here, we show that L-PTC\/B\n                    <jats:sup>Okra<\/jats:sup>\n                    is predominantly absorbed through enterocytes, whereas LPTC\/A\n                    <jats:sup>62A<\/jats:sup>\n                    targets intestinal microfold cells. Furthermore, \u03b11,2-fucosylation of intestinal mucin determines the oral toxicity of L-PTCs as well as their entry routes, due to differential carbohydrate-binding spectrum of one of the L-PTC components, the hemagglutinin (HA) complex. Fucosylation-deficient mice display reduced intestinal mucin penetration of L-PTC\/B\n                    <jats:sup>Okra<\/jats:sup>\n                    via HA, and lower susceptibility to oral intoxication with this toxin. Thus, our results shed light on the molecular mechanisms by which the oral toxicity of BoNTs is increased after crossing intestinal mucus layers\n                  <\/jats:p>","DOI":"10.1038\/s41467-025-65384-w","type":"journal-article","created":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T13:42:25Z","timestamp":1764078145000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Gut mucin fucosylation dictates the entry of botulinum toxin complexes"],"prefix":"10.1038","volume":"16","author":[{"given":"Sho","family":"Amatsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuhiro","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiyono","family":"Morimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunanda","family":"Keisham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Kohda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Kitadokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takane","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7307-4658","authenticated-orcid":false,"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3006-1659","authenticated-orcid":false,"given":"Hiroaki","family":"Tateno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Zuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8623-1376","authenticated-orcid":false,"given":"Yukako","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,25]]},"reference":[{"key":"65384_CR1","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1152\/physrev.2000.80.2.717","volume":"80","author":"G Schiavo","year":"2000","unstructured":"Schiavo, G., Matteoli, M. & Montecucco, C. Neurotoxins affecting neuroexocytosis. Physiol. Rev. 80, 717\u2013766 (2000).","journal-title":"Physiol. Rev."},{"key":"65384_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0163-7258(82)90061-4","volume":"19","author":"G Sakaguchi","year":"1982","unstructured":"Sakaguchi, G. Clostridium botulinum toxins. Pharmacol. Ther. 19, 165\u2013194 (1982).","journal-title":"Pharmacol. Ther."},{"key":"65384_CR3","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1128\/iai.16.3.910-914.1977","volume":"16","author":"S Sugii","year":"1977","unstructured":"Sugii, S., Ohishi, I. & Sakaguchi, G. Correlation between oral toxicity and in vitro stability of Clostridium botulinum type A and B toxins of different molecular sizes. Infect. Immun. 16, 910\u2013914 (1977).","journal-title":"Infect. Immun."},{"key":"65384_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1126\/science.1214270","volume":"335","author":"S Gu","year":"2012","unstructured":"Gu, S. et al. Botulinum neurotoxin is shielded by NTNHA in an interlocked complex. Science 335, 977\u2013981 (2012).","journal-title":"Science"},{"key":"65384_CR5","doi-asserted-by":"publisher","first-page":"35617","DOI":"10.1074\/jbc.M113.521179","volume":"288","author":"S Amatsu","year":"2013","unstructured":"Amatsu, S., Sugawara, Y., Matsumura, T., Kitadokoro, K. & Fujinaga, Y. Crystal structure of Clostridium botulinum whole hemagglutinin reveals a huge triskelion-shaped molecular complex. J. Biol. Chem. 288, 35617\u201335625 (2013).","journal-title":"J. Biol. Chem."},{"key":"65384_CR6","first-page":"355","volume":"10","author":"T Matsumura","year":"2008","unstructured":"Matsumura, T. et al. The HA proteins of botulinum toxin disrupt intestinal epithelial intercellular junctions to increase toxin absorption. Cell. Microbiol. 10, 355\u2013364 (2008).","journal-title":"Cell. Microbiol."},{"key":"65384_CR7","first-page":"45","volume":"364","author":"Y Fujinaga","year":"2013","unstructured":"Fujinaga, Y., Sugawara, Y. & Matsumura, T. Uptake of botulinum neurotoxin in the intestine. Curr. Top. Microbiol. Immunol. 364, 45\u201359 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"65384_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7255","volume":"6","author":"T Matsumura","year":"2015","unstructured":"Matsumura, T. et al. Botulinum toxin A complex exploits intestinal M cells to enter the host and exert neurotoxicity. Nat. Commun. 6, 6255 (2015).","journal-title":"Nat. Commun."},{"key":"65384_CR9","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1083\/jcb.200910119","volume":"189","author":"Y Sugawara","year":"2010","unstructured":"Sugawara, Y. et al. Botulinum hemagglutinin disrupts the intercellular epithelial barrier by directly binding E-cadherin. J. Cell Biol. 189, 691\u2013700 (2010).","journal-title":"J. Cell Biol."},{"key":"65384_CR10","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1126\/science.1253823","volume":"344","author":"K Lee","year":"2014","unstructured":"Lee, K. et al. Molecular basis for disruption of E-cadherin adhesion by botulinum neurotoxin A complex. Science 344, 1405\u20131410 (2014).","journal-title":"Science"},{"key":"65384_CR11","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41594-024-01479-0","volume":"32","author":"L Gao","year":"2025","unstructured":"Gao, L. et al. Botulinum neurotoxins exploit host digestive proteases to boost their oral toxicity via activating OrfXs\/P47. Nat. Struct. Mol. Biol. 32, 864\u2013875 (2025).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"65384_CR12","first-page":"1","volume":"364","author":"KK Hill","year":"2013","unstructured":"Hill, K. K. & Smith, T. J. Genetic Diversity Within Clostridium botulinum Serotypes, Botulinum neurotoxin gene clusters and toxin subtypes. Curr. Top. Microbiol. Immunol. 364, 1\u201320 (2013).","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"65384_CR13","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/toxins11120686","volume":"11","author":"O Rossetto","year":"2019","unstructured":"Rossetto, O. & Montecucco, C. Tables of toxicity of botulinum and tetanus neurotoxins. Toxins 11, 686 (2019).","journal-title":"Toxins"},{"key":"65384_CR14","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.1002\/1873-3468.13508","volume":"593","author":"S Pellett","year":"2019","unstructured":"Pellett, S., Tepp, W. H. & Johnson, E. A. Botulinum neurotoxins A, B, C, E, and F preferentially enter cultured human motor neurons compared to other cultured human neuronal populations. FEBS Lett. 593, 2675\u20132685 (2019).","journal-title":"FEBS Lett."},{"key":"65384_CR15","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1146\/annurev.physiol.010908.163145","volume":"71","author":"LG Van Der Flier","year":"2009","unstructured":"Van Der Flier, L. G. & Clevers, H. Stem Cells, Self-renewal, and differentiation in the intestinal epithelium. Annu. Rev. Physiol. 71, 241\u2013260 (2009).","journal-title":"Annu. Rev. Physiol."},{"key":"65384_CR16","doi-asserted-by":"publisher","first-page":"407","DOI":"10.4161\/gmic.1.6.14078","volume":"1","author":"H Ohno","year":"2010","unstructured":"Ohno, H. & Hase, K. Glycoprotein 2 (GP2). Gut Microbes. 1, 407\u2013410 (2010).","journal-title":"Gut Microbes"},{"key":"65384_CR17","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrmicro2538","volume":"9","author":"MA McGuckin","year":"2011","unstructured":"McGuckin, M. A., Lind\u00e9n, S. K., Sutton, P. & Florin, T. H. Mucin dynamics and enteric pathogens. Nat. Rev. Microbiol. 9, 265\u2013278 (2011).","journal-title":"Nat. Rev. Microbiol."},{"key":"65384_CR18","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre, B., Barayeu, U., Ezeri\u0146a, D. & Dick, T. P. The mechanism of action of N-acetylcysteine (NAC): The emerging role of H2S and sulfane sulfur species. Pharmacol. Ther. 228, 107916 (2021).","journal-title":"Pharmacol. Ther."},{"key":"65384_CR19","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/toxins17090443","volume":"17","author":"C Morimoto","year":"2025","unstructured":"Morimoto, C., Amatsu, S., Matsumura, T., Zuka, M. & Fujinaga, Y. Botulinum toxin complex serotype B-Okra exerts systemic toxicity via oral route by disrupting the intestinal epithelial barrier. Toxins 17, 443 (2025).","journal-title":"Toxins"},{"key":"65384_CR20","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-0716-0430-4_19","volume":"2132","author":"S Amatsu","year":"2020","unstructured":"Amatsu, S. & Fujinaga, Y. Botulinum hemagglutinin: Critical protein for adhesion and absorption of neurotoxin complex in host intestine. Methods Mol. Biol. 2132, 183\u2013190 (2020).","journal-title":"Methods Mol. Biol."},{"key":"65384_CR21","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.bbrc.2014.03.008","volume":"446","author":"K Lee","year":"2014","unstructured":"Lee, K. et al. High-resolution crystal structure of HA33 of botulinum neurotoxin type B progenitor toxin complex. Biochem. Biophys. Res. Commun. 446, 568\u2013573 (2014).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"65384_CR22","doi-asserted-by":"publisher","first-page":"e1003690","DOI":"10.1371\/journal.ppat.1003690","volume":"9","author":"K Lee","year":"2013","unstructured":"Lee, K. et al. Structure of a bimodular botulinum neurotoxin complex provides insights into its oral toxicity. PLoS Pathog. 9, e1003690 (2013).","journal-title":"PLoS Pathog."},{"key":"65384_CR23","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1093\/glycob\/cwt045","volume":"23","author":"KSB Bergstrom","year":"2013","unstructured":"Bergstrom, K. S. B. & Xia, L. Mucin-type O-glycans and their roles in intestinal homeostasis. Glycobiology 23, 1026\u20131037 (2013).","journal-title":"Glycobiology"},{"key":"65384_CR24","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1021\/acschembio.1c00689","volume":"17","author":"D Bojar","year":"2022","unstructured":"Bojar, D. et al. A Useful Guide to Lectin binding: Machine-learning directed annotation of 57 unique lectin specificities. ACS Chem. Biol. 17, 2993\u20133012 (2022).","journal-title":"ACS Chem. Biol."},{"key":"65384_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/1348-0421.12565","volume":"62","author":"S Amatsu","year":"2018","unstructured":"Amatsu, S., Matsumura, T., Yutani, M. & Fujinaga, Y. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption. Microbiol. Immunol. 62, 80\u201389 (2018).","journal-title":"Microbiol. Immunol."},{"key":"65384_CR26","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1128\/JB.186.15.4885-4893.2004","volume":"186","author":"T Katayama","year":"2004","unstructured":"Katayama, T. et al. Molecular cloning and characterization of Bifidobacterium bifidum 1,2-\u03b1-l-fucosidase (AfcA), a novel inverting glycosidase (glycoside hydrolase family 95). J. Bacteriol. 186, 4885\u20134893 (2004).","journal-title":"J. Bacteriol."},{"key":"65384_CR27","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1042\/bj3340685","volume":"334","author":"C Wickstr\u00f6m","year":"1998","unstructured":"Wickstr\u00f6m, C., Davies, J. R., Eriksen, G. V., Veerman, E. C. & Carlstedt, I. MUC5B is a major gel-forming, oligomeric mucin from human salivary gland, respiratory tract and endocervix: identification of glycoforms and C-terminal cleavage. Biochem. J. 334, 685\u2013693 (1998).","journal-title":"Biochem. J."},{"key":"65384_CR28","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1074\/mcp.M117.067983","volume":"16","author":"C Jin","year":"2017","unstructured":"Jin, C. et al. Structural diversity of human gastric mucin glycans. Mol. Cell. Proteom. 16, 743\u2013758 (2017).","journal-title":"Mol. Cell. Proteom."},{"key":"65384_CR29","doi-asserted-by":"publisher","first-page":"940196","DOI":"10.3389\/fmicb.2022.940196","volume":"13","author":"M Hu","year":"2022","unstructured":"Hu, M. et al. Fucosyltransferase 2: a genetic risk factor for intestinal diseases. Front. Microbiol. 13, 940196 (2022).","journal-title":"Front. Microbiol."},{"key":"65384_CR30","doi-asserted-by":"publisher","first-page":"41R","DOI":"10.1093\/glycob\/cwg054","volume":"13","author":"DJ Becker","year":"2003","unstructured":"Becker, D. J. & Lowe, J. B. Fucose: biosynthesis and biological function in mammals. Glycobiology 13, 41R\u201353R (2003).","journal-title":"Glycobiology"},{"key":"65384_CR31","doi-asserted-by":"publisher","first-page":"1254009","DOI":"10.1126\/science.1254009","volume":"345","author":"Y Goto","year":"2014","unstructured":"Goto, Y. et al. Innate lymphoid cells regulate intestinal epithelial cell glycosylation. Science 345, 1254009 (2014).","journal-title":"Science"},{"key":"65384_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1111\/mmi.14681","volume":"115","author":"JM Garber","year":"2021","unstructured":"Garber, J. M., Hennet, T. & Szymanski, C. M. Significance of fucose in intestinal health and disease. Mol. Microbiol. 115, 1086\u20131093 (2021).","journal-title":"Mol. Microbiol."},{"key":"65384_CR33","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.tim.2021.06.003","volume":"30","author":"C Belzer","year":"2022","unstructured":"Belzer, C. Nutritional strategies for mucosal health: the interplay between microbes and mucin glycans. Trends Microbiol. 30, 13\u201321 (2022).","journal-title":"Trends Microbiol."},{"key":"65384_CR34","doi-asserted-by":"publisher","first-page":"25256","DOI":"10.1074\/jbc.M111.233601","volume":"286","author":"N Ishijima","year":"2011","unstructured":"Ishijima, N. et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J. Biol. Chem. 286, 25256\u201325264 (2011).","journal-title":"J. Biol. Chem."},{"key":"65384_CR35","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/acsinfecdis.7b00085","volume":"4","author":"AM Wands","year":"2018","unstructured":"Wands, A. M. et al. Fucosylated molecules competitively interfere with cholera toxin Binding to host cells. ACS Infect. Dis. 4, 758\u2013770 (2018).","journal-title":"ACS Infect. Dis."},{"key":"65384_CR36","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1021\/acsinfecdis.0c00009","volume":"6","author":"J Cervin","year":"2020","unstructured":"Cervin, J. et al. Fucose-galactose polymers inhibit cholera toxin binding to fucosylated structures and galactose-dependent intoxication of human enteroids. ACS Infect. Dis. 6, 1192\u20131203 (2020).","journal-title":"ACS Infect. Dis."},{"key":"65384_CR37","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.1128\/JVI.79.11.6714-6722.2005","volume":"79","author":"P Huang","year":"2005","unstructured":"Huang, P. et al. Norovirus and histo-blood group antigens: Demonstration of a wide spectrum of strain specificities and classification of two major binding groups among multiple binding patterns. J. Virol. 79, 6714\u20136722 (2005).","journal-title":"J. Virol."},{"key":"65384_CR38","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/glycob\/cww070","volume":"27","author":"A Mallagaray","year":"2017","unstructured":"Mallagaray, A., Rademacher, C., Parra, F., Hansman, G. & Peters, T. Saturation transfer difference nuclear magnetic resonance titrations reveal complex multistep-binding of l-fucose to norovirus particles. Glycobiology 27, 80\u201386 (2017).","journal-title":"Glycobiology"},{"key":"65384_CR39","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fcimb.2018.00372","volume":"8","author":"I Azagra-Boronat","year":"2018","unstructured":"Azagra-Boronat, I. et al. Supplementation with 2\u2019-FL and scGOS\/lcFOS ameliorates rotavirus-induced diarrhea in suckling rats. Front. Cell. Infect. Microbiol. 8, 372 (2018).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"65384_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/jb\/mvv121","volume":"159","author":"H Ohno","year":"2016","unstructured":"Ohno, H. Intestinal M cells. J. Biochem. 159, 151\u2013160 (2016).","journal-title":"J. Biochem."},{"key":"65384_CR41","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1177\/002215549704501003","volume":"45","author":"A Gebert","year":"1997","unstructured":"Gebert, A. & Posselt, W. Glycoconjugate expression defines the origin and differentiation pathway of intestinal M-cells. J. Histochem. Cytochem. 45, 1341\u20131350 (1997).","journal-title":"J. Histochem. Cytochem."},{"key":"65384_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1017\/S0950268800048366","volume":"106","author":"A Mentis","year":"1991","unstructured":"Mentis, A. et al. ABO blood group, secretor status and detection of Helicobacter pylori among patients with gastric or duodenal ulcers. Epidemiol. Infect. 106, 221\u2013229 (1991).","journal-title":"Epidemiol. Infect."},{"key":"65384_CR43","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/0035-9203(78)90031-7","volume":"72","author":"A Chaudhuri","year":"1978","unstructured":"Chaudhuri, A. & DasAdhikary, C. R. Possible role of blood-group secretory substances in the aetiology of cholera. Trans. R. Soc. Trop. Med. Hyg. 72, 664\u2013665 (1978).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"65384_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-10854-5","volume":"7","author":"L Mottram","year":"2017","unstructured":"Mottram, L., Wiklund, G., Larson, G., Qadri, F. & Svennerholm, A.-M. FUT2 non-secretor status is associated with altered susceptibility to symptomatic enterotoxigenic Escherichia coli infection in Bangladeshis. Sci. Rep. 7, 10649 (2017).","journal-title":"Sci. Rep."},{"key":"65384_CR45","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/nm860","volume":"9","author":"L Lindesmith","year":"2003","unstructured":"Lindesmith, L. et al. Human susceptibility and resistance to Norwalk virus infection. Nat. Med. 9, 548\u2013553 (2003).","journal-title":"Nat. Med."},{"key":"65384_CR46","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1093\/infdis\/jit655","volume":"209","author":"B-M Imbert-Marcille","year":"2014","unstructured":"Imbert-Marcille, B.-M. et al. A FUT2 gene common polymorphism determines resistance to rotavirus A of the P[8] genotype. J. Infect. Dis. 209, 1227\u20131230 (2014).","journal-title":"J. Infect. Dis."},{"key":"65384_CR47","doi-asserted-by":"publisher","first-page":"eaaz4179","DOI":"10.1126\/scitranslmed.aaz4197","volume":"13","author":"S-I Miyashita","year":"2021","unstructured":"Miyashita, S.-I., Zhang, J., Zhang, S., Shoemaker, C. B. & Dong, M. Delivery of single-domain antibodies into neurons using a chimeric toxin\u2013based platform is therapeutic in mouse models of botulism. Sci. Transl. Med. 13, eaaz4179 (2021).","journal-title":"Sci. Transl. Med."},{"key":"65384_CR48","doi-asserted-by":"publisher","first-page":"eabd7789","DOI":"10.1126\/scitranslmed.abd7789","volume":"13","author":"PM McNutt","year":"2021","unstructured":"McNutt, P. M. et al. Neuronal delivery of antibodies has therapeutic effects in animal models of botulism. Sci. Transl. Med. 13, eabd7789 (2021).","journal-title":"Sci. Transl. Med."},{"key":"65384_CR49","doi-asserted-by":"publisher","first-page":"e00528","DOI":"10.1128\/genomeA.00528-18","volume":"6","author":"TG Wentz","year":"2018","unstructured":"Wentz, T. G. et al. Closed genome sequence of Clostridium botulinum strain CFSAN064329 (62A). Genome Announc. 6, e00528\u201318 (2018).","journal-title":"Genome Announc."},{"key":"65384_CR50","doi-asserted-by":"publisher","first-page":"e01010","DOI":"10.1128\/genomeA.01010-13","volume":"2","author":"Y Sakaguchi","year":"2014","unstructured":"Sakaguchi, Y. et al. Draft Genome sequence of Clostridium botulinum type B strain Osaka05, isolated from an infant patient with botulism in Japan. Genome Announc. 2, e01010\u2013e01013 (2014).","journal-title":"Genome Announc."},{"key":"65384_CR51","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1099\/mic.0.021246-0","volume":"155","author":"Y Jin","year":"2009","unstructured":"Jin, Y., Takegahara, Y., Sugawara, Y., Matsumura, T. & Fujinaga, Y. Disruption of the epithelial barrier by botulinum haemagglutinin (HA) proteins - differences in cell tropism and the mechanism of action between HA proteins of types A or B, and HA proteins of type C. Microbiology 155, 35\u201345 (2009).","journal-title":"Microbiology"},{"key":"65384_CR52","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60, 2126\u20132132 (2004).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"65384_CR53","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1107\/S0907444911001314","volume":"67","author":"GN Murshudov","year":"2011","unstructured":"Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D Biol. Crystallogr. 67, 355 (2011).","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"65384_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbrc.2021.12.041","volume":"590","author":"JA Bhayani","year":"2022","unstructured":"Bhayani, J. A. & Ballicora, M. A. Determination of dissociation constants of protein ligands by thermal shift assay. Biochem. Biophys. Res. Commun. 590, 1\u20136 (2022).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"65384_CR55","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1093\/glycob\/cwn068","volume":"18","author":"H Tateno","year":"2008","unstructured":"Tateno, H. et al. Glycoconjugate microarray based on an evanescent-field fluorescence-assisted detection principle for investigation of glycan-binding proteins. Glycobiology 18, 789\u2013798 (2008).","journal-title":"Glycobiology"},{"key":"65384_CR56","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S0531-5131(03)01535-8","volume":"1261","author":"Y Itoh","year":"2004","unstructured":"Itoh, Y., Takahashi, K., Satoh, K., Nagao, K. & Fujime, M. Multiplex PCR with confronting two-pair primers for Se genotyping. Int. Congr. Ser. 1261, 602\u2013604 (2004).","journal-title":"Int. Congr. Ser."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65384-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65384-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T15:05:36Z","timestamp":1764083136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-65384-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,25]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["65384"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-65384-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,25]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"10442"}}